An update on the hepatitis e virus

Current Gastroenterology Reports

Volumn 15, Issue 2, 2013, Pages

  Sclair, Seth N ^a   Schiff, Eugene R ^a  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

Chronic liver disease; Cirrhosis; DILI; Hepatitis; Hepatitis E; Pregnancy; Ribavirin; Transplantation; Vaccine; Zoonosis

Indexed keywords

HEPATITIS E VACCINE; LIVER ENZYME; PLACEBO; RIBAVIRIN;

ARTICLE; CHRONIC LIVER DISEASE; ENZYME BLOOD LEVEL; FOOD INTAKE; GRAFT RECIPIENT; HEPATITIS E; HEPATITIS E VIRUS; HEPATITIS E VIRUS GENOTYPE 3; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOCOMPROMISED PATIENT; LIVER CIRRHOSIS; LIVER FIBROSIS; MIXED INFECTION; MORBIDITY; MORTALITY; NONHUMAN; PHASE 2 CLINICAL TRIAL (TOPIC); PHASE 3 CLINICAL TRIAL (TOPIC); PREGNANT WOMAN; PREVALENCE; RANDOMIZED CONTROLLED TRIAL (TOPIC); VACCINATION; VIRAL CLEARANCE;

EID: 84872060975     PISSN: 15228037     EISSN: 1534312X     Source Type: Journal    
DOI: 10.1007/s11894-012-0304-2     Document Type: Article

References (39)

1. Balayan MS, Andjaparidze AG, Savinskaya SS, et al. Evidence for a virus in non-A, non-B hepatitis transmitted via the fecal-oral route. Intervirology. 1983;20(1):23-31. (Pubitemid 13105502)
2. Reyes GR, Purdy MA, Kim JP, et al. Isolation of a cDNA from the virus responsible for enterically transmitted non-A, non-B hepatitis. Science. 1990;247(4948):1335-9.
3. Yarbough PO, Tam AW, Fry KE, et al. Hepatitis E Virus: identification of type-common epitopes. J Virol. 1991;65(11):5790-7.
4. Davern TJ, Chalsani N, Fontana RJ, et al. Acute hepatitis E infection accounts for some cases of suspected drug-induced liver injury. Gastroenterology. 2011;141:1666-72.
5. Dalton HR, Fellows HJ, Stableforth W, et al. The role of hepatitis E virus testing in drug-induced liver injury. Aliment Pharmacol Ther. 2007;26:1429-35. (Pubitemid 350045603)
6. Dalton HR, Hazeldine S, Banks M, et al. Locally acquired hepatitis E in chronic liver disease. Lancet. 2007;369:1260. (Pubitemid 46566523)
7. Peron JM, Bureau C, Poirson H, et al. Fulminant liver failure from acute autochthonous hepatitis E in France: description of seven patients with acute hepatitis E and encephalopathy. J Viral Hepat. 2007;14:298-303. (Pubitemid 46587857)
8. Suzuki K, Aikawa T, Okamato H. Fulminant Hepatitis E in Japan. N Engl J Med. 2002;347:1456.
9. Okamoto H, Takahashi M, Nishizawa T. Features of hepatitis E virus infection in Japan. Intern Med. 2003;42:1065-71. (Pubitemid 38016383)
10. Kumar Acharya S, Kumar Sharma P, Singh R, et al. Hepatitis E virus (HEV) infection in patients with cirrhosis is associated with rapid decompensation and death. J Hepatol. 2007;46:387-94. (Pubitemid 46185699)
11. Ramachandran J, Eapen CE, Kang G, et al. Hepatitis E superinfection produces severe decompensation in patients with chronic liver disease. J Gastroenterol Hepatol. 2004;19:134-8. (Pubitemid 38253351)
12. Dalton HR. Hepatitis E, and decompensated chronic liver disease. Nat Rev Gastroenterol Hepatol. 2012;9:430-2.
13. Dalton HR, Bendall RP, Pritchard C, et al. National mortality rates from chronic liver disease and consumption of alcohol and pig meat. Epidemiol Infect. 2010;2:174-82.
14. Tsega E, Krawczynski K, Hansson BG, et al. Hepatitis E virus infection in pregnancy in Ethiopia. Ethiop Med J. 1993;31:173-81. (Pubitemid 23252699)
15. Anty R, Ollier L, Peron JM, et al. First case report of an acute genotype 3 hepatitis E infected pregnant woman living in South France. J Clin Virol. 2012;54:76-8.
16. Tavitan S, Peron JM, Huynh A, et al. Hepatitis E virus excretion can be prolonged in patients with hematological malignancies. J Clin Virol. 2010;49:141-4.
17. Ollier L, Tieulie N, Sanderson F, et al. Chronic hepatitis after hepatitis E virus infection in a patient with non-Hodgkin lymphoma taking rituximab. Ann Intern Med. 2009;150: 430-1.
18. Kamar N, Selves J, Mansuy JM, et al. Hepatitis E virus and chronic Hepatitis in organ-transplant recipients. N Engl J Med. 2008;358:811-7. (Pubitemid 351281642)
19. Gerolami R, Moal V, Colson P, et al. Chronic hepatitis E with cirrhosis in a kidney transplant recipient. N Engl J Med. 2008; 859-60. (Pubitemid 351281667)
20. Kamar N, Abravanel F, Selves J, et al. Influence of immunosuppressive therapy on the natural histrory of genotype 3 hepatitis-E virus infection after organ transplantation. Transplantation. 2010;89:353-60.
21. Legrand-Abravanel F, Kamar N, Sandres-Saune K, et al. Characteristics of autochthonous hepatitis E virus infection in solid-organ transplant recipients in France. J Infect Dis. 2010;202:835-44.
22. Pischke S, Suneetha PV, Baechlein C, et al. Hepatitis E virus infection as a cause of graft hepatitis in liver transplant recipients. Liver Transpl. 2010;16:74-82.
23. Kumar N, Garrouste C, Haagsma EB, et al. Factors associated with chronic hepatitis in patients with hepatitis E virus infection who have received solid organ transplants. Gastroenterology. 2011;140:1481-9.
24. Dalton H, et al. Persistent carriage of hepatitis E virus in patient with HIV infection. N Engl J Med. 2009;361:1025-7.
25. Crum-Cianflone NF, Curry J, Drobeniuc J, et al. Hepatitis E virus infection in HIV-infected persons. Emerg Infect Dis. 2012;18:502-6.
26. Peron JM, Dalton H, Izopet J, et al. Acute autochthonous hepatitis E in western patients with underlying chronic disease: a role for ribavirin? J Hepatol. 2011;54:1323-5.
27. Gerolami R, Borentain P, Raissouni F, et al. Treatment of severe acute hepatitis E by ribavirin. J Clin Virol. 2011;52:60-2.
28. Kamar N, Abravanel F, Garrouste C, et al. Three month pegylated interferon-alpha-2a therapy for chronic hepatitis E virus infection in a haemodialysis patient. Nephrol Dial Transplant. 2010;25:2792-5.
29. Kamar N, Rostaing L, Abravanel F, et al. Ribavirin inhibits viral replication on patients with chronic hepatitis E virus infection. Gastroenterology. 2010;139:1612-8.
30. Wedemeyer H, Pischke S, Manns MP, et al. Pathogenesis and treatment of hepatitis E virus infection. Gastroenterology. 2012;142:1388-97.
31. Haagsma EB, Riezebos-Brilman A, van den Berg AP, et al. Treatment of chronic hepatitis E in liver transplant recipients with pegylated interferon alpha 2b. Liver Transpl. 2010;16: 474-7.
32. Kamar N, Rostaing L, Abravanel F, et al. Pegylated interferonalpha for treating chronic hepatitis E virus infection after liver transplantation. Clin Infect Dis. 2010;50:30-3.
33. Alric L, Bonnet D, Laurent G, et al. Chronic hepatitis E virus infection: successful virologic response to pegylated Interferonalpha therapy. Ann Intern Med. 2010;153:135-6.
34. Alric L, Bonnet D, Beynes-Rauzy O, et al. Definitive clearance of a chronic hepatitis E virus infection with ribavirin treatment. Am J Gastroenterol. 2011;106:1562-3.
35. Mallet V, Nicand E, Sultanik P, et al. Brief communication: case reports of ribavirin treatement for chronic hepatitis E. Ann Intern Med. 2010;153:85-9.
36. Dalton HR, Keane FE, Bendall R, et al. Treatment of chronic hepatitis E in a patient with HIV infection. Ann Intern Med. 2011;155:479-80.
37. Aggarwal R. HEV vaccine, where are we? Presented at the International Liver Congress 2012. Barcelona, Spain. April 20, 2012.
38. Shrestha MP, Scott RM, Joshi DM, et al. Safety and efficacy of a recombinant hepatitis E vaccine. N Engl J Med. 2007;356:895-903. (Pubitemid 46339908)
39. Zhu FC, Zhang J, Zhang XF, et al. Efficacy and safety of a recombinant HEV vaccine in healthy adults: a large scale, radomised, double-blind, placebo controlled, phase 3 trial. Lancet. 2010;376:895-902.